UMIN ID: UMIN000002013
Registered date:29/05/2009
Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
Basic Information
| Recruitment status | Complete: follow-up continuing |
|---|---|
| Health condition(s) or Problem(s) studied | Colon cancer |
| Date of first enrollment | 2009/04/01 |
| Target sample size | 3000 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Relationship between expression levels of the enzymes and DFS, RFS, OS and adverse effects. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) Synchronous or metachronous multiple cancers 2) Contraindication of FU drugs 3) The investigator considers not suitable for the study |
Related Information
| Primary Sponsor | Tokyo Medical and Dental University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Foundation for Biochemical Research and Innovation |
| Secondary ID(s) | NCT00918827 |
Contact
| public contact | |
| Name | Kenichi Sugihara, M.D., PhD |
| Address | 1-5-45, Yushima , Bunkyo-ku, Tokyo, 113-8519, Japan Japan |
| Telephone | 03-5803-5261 |
| k-sugi.srg2@tmd.ac.jp | |
| Affiliation | Tokyo Medical and Dental University, Graduate School Dept. of Surgical Oncology |
| scientific contact | |
| Name | Kenichi Sugihara, M.D., PhD |
| Address | 1-5-45, Yushima , Bunkyo-ku, Tokyo, 113-8519, Japan Japan |
| Telephone | 03-5803-5261 |
| Affiliation | Tokyo Medical and Dental University, Graduate School Dept. of Surgical Oncology |